HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pei-Yu Kuo Selected Research

ON123300

3/2016Dual Targeting of CDK4 and ARK5 Using a Novel Kinase Inhibitor ON123300 Exerts Potent Anticancer Activity against Multiple Myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pei-Yu Kuo Research Topics

Disease

2Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
09/2015 - 08/2010
2Lymphoma (Lymphomas)
09/2015 - 01/2014
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2014 - 05/2012
1Multiple Myeloma
03/2016
1Neoplasms (Cancer)
03/2016
1Glioblastoma (Glioblastoma Multiforme)
01/2014

Drug/Important Bio-Agent (IBA)

2DNA (Deoxyribonucleic Acid)IBA
09/2015 - 01/2014
2Pharmaceutical PreparationsIBA
01/2014 - 08/2010
1ON123300IBA
03/2016
1Phosphotransferases (Kinase)IBA
03/2016
1Protein Kinases (Protein Kinase)IBA
03/2016
1Bortezomib (Velcade)FDA Link
09/2015
1Proteasome InhibitorsIBA
09/2015
1DecitabineFDA Link
09/2015
1Transcription Factors (Transcription Factor)IBA
01/2014
1Alkylating AgentsIBA
01/2014
1Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA
01/2014
1Proteins (Proteins, Gene)FDA Link
01/2014
1Temozolomide (Temodar)FDA LinkGeneric
01/2014
1MK 2206IBA
05/2012
1Nelfinavir (Viracept)FDA Link
05/2012

Therapy/Procedure

2Therapeutics
03/2016 - 01/2014